These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
593 related items for PubMed ID: 15735310
21. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors. Japanese Red Cross NAT Screening Research GroupJapanese Red Cross Plasma Fractionation Center, Tokyo 105-0013, Japan.. Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709 [Abstract] [Full Text] [Related]
22. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal]. Koch C, Araújo F. Acta Med Port; 2013 Jun; 26(4):371-6. PubMed ID: 24016646 [Abstract] [Full Text] [Related]
23. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Moiz B, Moatter T, Shaikh U, Adil S, Ali N, Mahar F, Shamsuddin N, Khurshid M. Transfusion; 2014 Jun; 54(6):1652-9. PubMed ID: 24383918 [Abstract] [Full Text] [Related]
24. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK, Marwaha N, Bhatia NK, Ganguly AK. Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791 [Abstract] [Full Text] [Related]
27. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Jarvis LM, Dow BC, Cleland A, Davidson F, Lycett C, Morris K, Webb B, Jordan A, Petrik J. Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504 [Abstract] [Full Text] [Related]
28. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
29. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512 [Abstract] [Full Text] [Related]
30. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Lętowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW. Vox Sang; 2012 Jan 27; 102(1):82-90. PubMed ID: 21933190 [No Abstract] [Full Text] [Related]
31. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR, Kiely P, Keller AJ. Intern Med J; 2005 Oct 27; 35(10):592-8. PubMed ID: 16207258 [Abstract] [Full Text] [Related]
32. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. van Hulst M, Hubben GA, Sagoe KW, Promwong C, Permpikul P, Fongsatitkul L, Glynn DM, Sibinga CT, Postma MJ. Transfusion; 2009 Dec 27; 49(12):2729-42. PubMed ID: 19709093 [Abstract] [Full Text] [Related]
33. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. O'Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP. Vox Sang; 2012 Jul 27; 103(1):83-6. PubMed ID: 22289147 [Abstract] [Full Text] [Related]
34. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP. Transfusion; 2005 Feb 27; 45(2):133-40. PubMed ID: 15660820 [Abstract] [Full Text] [Related]
36. [HIV, HCV, HBV and syphilis infections among blood donors in Germany 2005. Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act]. Offergeld R, Ritter S, Hamouda O. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Oct 27; 50(10):1221-31. PubMed ID: 17924066 [Abstract] [Full Text] [Related]
38. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Shang G, Seed CR, Wang F, Nie D, Farrugia A. Transfusion; 2007 Mar 27; 47(3):529-39. PubMed ID: 17319836 [Abstract] [Full Text] [Related]
40. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH, Tiemuer MH, Tu YQ, Zhu FM, Zheng YR, Cui L, Liu CL, Gong XY, Lv QS, Zheng P, Ziermann R, Ness P, Wang JX. Transfusion; 2007 Nov 27; 47(11):2011-6. PubMed ID: 17958529 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]